PDB Short entry for 1RO8 HEADER TRANSFERASE 01-DEC-03 1RO8 TITLE STRUCTURAL ANALYSIS OF THE SIALYLTRANSFERASE CSTII FROM CAMPYLOBACTER TITLE 2 JEJUNI IN COMPLEX WITH A SUBSTRATE ANALOGUE, CYTIDINE-5'- TITLE 3 MONOPHOSPHATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-2,3/8-SIALYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.4.99.-; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CAMPYLOBACTER JEJUNI; SOURCE 3 ORGANISM_TAXID: 197; SOURCE 4 GENE: CST; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS MIXED ALPHA/BETA, ROSSMANN FOLD, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.P.CHIU,A.G.WATTS,L.L.LAIRSON,M.GILBERT,D.LIM,W.W.WAKARCHUK, AUTHOR 2 S.G.WITHERS,N.C.STRYNADKA REVDAT 3 27-OCT-21 1RO8 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1RO8 1 VERSN REVDAT 1 03-FEB-04 1RO8 0 JRNL AUTH C.P.CHIU,A.G.WATTS,L.L.LAIRSON,M.GILBERT,D.LIM, JRNL AUTH 2 W.W.WAKARCHUK,S.G.WITHERS,N.C.STRYNADKA JRNL TITL STRUCTURAL ANALYSIS OF THE SIALYLTRANSFERASE CSTII FROM JRNL TITL 2 CAMPYLOBACTER JEJUNI IN COMPLEX WITH A SUBSTRATE ANALOG. JRNL REF NAT.STRUCT.MOL.BIOL. V. 11 163 2004 JRNL REFN ISSN 1545-9993 JRNL PMID 14730352 JRNL DOI 10.1038/NSMB720 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2324601.260 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.0 REMARK 3 NUMBER OF REFLECTIONS : 60525 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2941 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.18 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 63.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6635 REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE : 0.2710 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 347 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3944 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 64 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -15.28000 REMARK 3 B22 (A**2) : -14.85000 REMARK 3 B33 (A**2) : 30.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.31 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.620 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 42.56 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : C1PMOD.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : &_1_TOPOLOGY_INFILE_2 REMARK 3 TOPOLOGY FILE 3 : &_1_TOPOLOGY_INFILE_3 REMARK 3 TOPOLOGY FILE 4 : &_1_TOPOLOGY_INFILE_4 REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RO8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1000020911. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97912, 0.97961, 0.97900 REMARK 200 MONOCHROMATOR : SI(111), (220) AND W-B4C REMARK 200 MULTILAYER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62730 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.09100 REMARK 200 <I/SIGMA(I)> FOR SHELL : 10.60 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, MPD, TRIS, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A TETRAMER GENERATED FROM ONE REMARK 300 MOLECULE IN THE ASYMMETRIC UNIT BY THE OPERATIONS: REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 115.43400 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 115.43400 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 115.43400 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 115.43400 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 175 REMARK 465 PRO A 176 REMARK 465 ASN A 177 REMARK 465 PHE A 178 REMARK 465 LYS A 179 REMARK 465 ASN A 180 REMARK 465 ASP A 181 REMARK 465 ASN A 182 REMARK 465 SER A 183 REMARK 465 HIS A 184 REMARK 465 TYR A 185 REMARK 465 ILE A 186 REMARK 465 GLY A 187 REMARK 465 ASN A 259 REMARK 465 GLY B -3 REMARK 465 SER B -2 REMARK 465 HIS B -1 REMARK 465 GLN B 157 REMARK 465 ASN B 158 REMARK 465 GLY B 159 REMARK 465 SER B 160 REMARK 465 SER B 161 REMARK 465 TYR B 162 REMARK 465 ALA B 163 REMARK 465 PHE B 164 REMARK 465 ASP B 165 REMARK 465 THR B 166 REMARK 465 LYS B 167 REMARK 465 GLN B 168 REMARK 465 LYS B 169 REMARK 465 ASN B 170 REMARK 465 LEU B 171 REMARK 465 LEU B 172 REMARK 465 LYS B 173 REMARK 465 LEU B 174 REMARK 465 ALA B 175 REMARK 465 PRO B 176 REMARK 465 ASN B 177 REMARK 465 PHE B 178 REMARK 465 LYS B 179 REMARK 465 ASN B 180 REMARK 465 ASP B 181 REMARK 465 ASN B 182 REMARK 465 SER B 183 REMARK 465 HIS B 184 REMARK 465 TYR B 185 REMARK 465 ILE B 186 REMARK 465 GLY B 187 REMARK 465 HIS B 188 REMARK 465 SER B 189 REMARK 465 ILE B 258 REMARK 465 ASN B 259 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A -2 65.77 -167.57 REMARK 500 MSE A 1 -30.99 81.72 REMARK 500 ASN A 31 -113.54 42.17 REMARK 500 GLN A 32 33.82 -90.37 REMARK 500 TYR A 156 73.84 48.79 REMARK 500 ASN A 158 -52.86 72.11 REMARK 500 ASN A 228 112.55 59.41 REMARK 500 ASN A 230 52.41 -104.77 REMARK 500 ASN B 23 -76.00 -65.03 REMARK 500 ASN B 31 -126.18 45.44 REMARK 500 GLN B 32 38.68 -80.79 REMARK 500 PHE B 155 34.08 35.81 REMARK 500 ASN B 237 -109.85 -101.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C5P B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C5P A 2001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RO7 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH CMP-3FNEUAC DBREF 1RO8 A 1 259 UNP Q9LAK3 Q9LAK3_CAMJE 1 259 DBREF 1RO8 B 1 259 UNP Q9LAK3 Q9LAK3_CAMJE 1 259 SEQADV 1RO8 GLY A -3 UNP Q9LAK3 CLONING ARTIFACT SEQADV 1RO8 SER A -2 UNP Q9LAK3 CLONING ARTIFACT SEQADV 1RO8 HIS A -1 UNP Q9LAK3 CLONING ARTIFACT SEQADV 1RO8 MSE A 1 UNP Q9LAK3 MET 1 MODIFIED RESIDUE SEQADV 1RO8 SER A 53 UNP Q9LAK3 ILE 53 ENGINEERED MUTATION SEQADV 1RO8 MSE A 77 UNP Q9LAK3 MET 77 MODIFIED RESIDUE SEQADV 1RO8 MSE A 136 UNP Q9LAK3 MET 136 MODIFIED RESIDUE SEQADV 1RO8 GLY A 222 UNP Q9LAK3 GLU 222 ENGINEERED MUTATION SEQADV 1RO8 GLY B -3 UNP Q9LAK3 CLONING ARTIFACT SEQADV 1RO8 SER B -2 UNP Q9LAK3 CLONING ARTIFACT SEQADV 1RO8 HIS B -1 UNP Q9LAK3 CLONING ARTIFACT SEQADV 1RO8 MSE B 1 UNP Q9LAK3 MET 1 MODIFIED RESIDUE SEQADV 1RO8 SER B 53 UNP Q9LAK3 ILE 53 ENGINEERED MUTATION SEQADV 1RO8 MSE B 77 UNP Q9LAK3 MET 77 MODIFIED RESIDUE SEQADV 1RO8 MSE B 136 UNP Q9LAK3 MET 136 MODIFIED RESIDUE SEQADV 1RO8 GLY B 222 UNP Q9LAK3 GLU 222 ENGINEERED MUTATION SEQRES 1 A 262 GLY SER HIS MSE LYS LYS VAL ILE ILE ALA GLY ASN GLY SEQRES 2 A 262 PRO SER LEU LYS GLU ILE ASP TYR SER ARG LEU PRO ASN SEQRES 3 A 262 ASP PHE ASP VAL PHE ARG CYS ASN GLN PHE TYR PHE GLU SEQRES 4 A 262 ASP LYS TYR TYR LEU GLY LYS LYS CYS LYS ALA VAL PHE SEQRES 5 A 262 TYR ASN PRO SER LEU PHE PHE GLU GLN TYR TYR THR LEU SEQRES 6 A 262 LYS HIS LEU ILE GLN ASN GLN GLU TYR GLU THR GLU LEU SEQRES 7 A 262 ILE MSE CYS SER ASN TYR ASN GLN ALA HIS LEU GLU ASN SEQRES 8 A 262 GLU ASN PHE VAL LYS THR PHE TYR ASP TYR PHE PRO ASP SEQRES 9 A 262 ALA HIS LEU GLY TYR ASP PHE PHE LYS GLN LEU LYS ASP SEQRES 10 A 262 PHE ASN ALA TYR PHE LYS PHE HIS GLU ILE TYR PHE ASN SEQRES 11 A 262 GLN ARG ILE THR SER GLY VAL TYR MSE CYS ALA VAL ALA SEQRES 12 A 262 ILE ALA LEU GLY TYR LYS GLU ILE TYR LEU SER GLY ILE SEQRES 13 A 262 ASP PHE TYR GLN ASN GLY SER SER TYR ALA PHE ASP THR SEQRES 14 A 262 LYS GLN LYS ASN LEU LEU LYS LEU ALA PRO ASN PHE LYS SEQRES 15 A 262 ASN ASP ASN SER HIS TYR ILE GLY HIS SER LYS ASN THR SEQRES 16 A 262 ASP ILE LYS ALA LEU GLU PHE LEU GLU LYS THR TYR LYS SEQRES 17 A 262 ILE LYS LEU TYR CYS LEU CYS PRO ASN SER LEU LEU ALA SEQRES 18 A 262 ASN PHE ILE GLY LEU ALA PRO ASN LEU ASN SER ASN PHE SEQRES 19 A 262 ILE ILE GLN GLU LYS ASN ASN TYR THR LYS ASP ILE LEU SEQRES 20 A 262 ILE PRO SER SER GLU ALA TYR GLY LYS PHE SER LYS ASN SEQRES 21 A 262 ILE ASN SEQRES 1 B 262 GLY SER HIS MSE LYS LYS VAL ILE ILE ALA GLY ASN GLY SEQRES 2 B 262 PRO SER LEU LYS GLU ILE ASP TYR SER ARG LEU PRO ASN SEQRES 3 B 262 ASP PHE ASP VAL PHE ARG CYS ASN GLN PHE TYR PHE GLU SEQRES 4 B 262 ASP LYS TYR TYR LEU GLY LYS LYS CYS LYS ALA VAL PHE SEQRES 5 B 262 TYR ASN PRO SER LEU PHE PHE GLU GLN TYR TYR THR LEU SEQRES 6 B 262 LYS HIS LEU ILE GLN ASN GLN GLU TYR GLU THR GLU LEU SEQRES 7 B 262 ILE MSE CYS SER ASN TYR ASN GLN ALA HIS LEU GLU ASN SEQRES 8 B 262 GLU ASN PHE VAL LYS THR PHE TYR ASP TYR PHE PRO ASP SEQRES 9 B 262 ALA HIS LEU GLY TYR ASP PHE PHE LYS GLN LEU LYS ASP SEQRES 10 B 262 PHE ASN ALA TYR PHE LYS PHE HIS GLU ILE TYR PHE ASN SEQRES 11 B 262 GLN ARG ILE THR SER GLY VAL TYR MSE CYS ALA VAL ALA SEQRES 12 B 262 ILE ALA LEU GLY TYR LYS GLU ILE TYR LEU SER GLY ILE SEQRES 13 B 262 ASP PHE TYR GLN ASN GLY SER SER TYR ALA PHE ASP THR SEQRES 14 B 262 LYS GLN LYS ASN LEU LEU LYS LEU ALA PRO ASN PHE LYS SEQRES 15 B 262 ASN ASP ASN SER HIS TYR ILE GLY HIS SER LYS ASN THR SEQRES 16 B 262 ASP ILE LYS ALA LEU GLU PHE LEU GLU LYS THR TYR LYS SEQRES 17 B 262 ILE LYS LEU TYR CYS LEU CYS PRO ASN SER LEU LEU ALA SEQRES 18 B 262 ASN PHE ILE GLY LEU ALA PRO ASN LEU ASN SER ASN PHE SEQRES 19 B 262 ILE ILE GLN GLU LYS ASN ASN TYR THR LYS ASP ILE LEU SEQRES 20 B 262 ILE PRO SER SER GLU ALA TYR GLY LYS PHE SER LYS ASN SEQRES 21 B 262 ILE ASN MODRES 1RO8 MSE A 1 MET SELENOMETHIONINE MODRES 1RO8 MSE A 77 MET SELENOMETHIONINE MODRES 1RO8 MSE A 136 MET SELENOMETHIONINE MODRES 1RO8 MSE B 1 MET SELENOMETHIONINE MODRES 1RO8 MSE B 77 MET SELENOMETHIONINE MODRES 1RO8 MSE B 136 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 77 8 HET MSE A 136 8 HET MSE B 1 8 HET MSE B 77 8 HET MSE B 136 8 HET C5P A2001 21 HET C5P B1001 21 HETNAM MSE SELENOMETHIONINE HETNAM C5P CYTIDINE-5'-MONOPHOSPHATE FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 C5P 2(C9 H14 N3 O8 P) FORMUL 5 HOH *64(H2 O) HELIX 1 1 GLY A 10 ILE A 16 5 7 HELIX 2 2 ASP A 17 LEU A 21 5 5 HELIX 3 3 GLN A 32 GLU A 36 5 5 HELIX 4 4 ASN A 51 SER A 53 5 3 HELIX 5 5 LEU A 54 ASN A 68 1 15 HELIX 6 6 ASN A 88 THR A 94 1 7 HELIX 7 7 THR A 94 PHE A 99 1 6 HELIX 8 8 GLY A 105 LYS A 110 1 6 HELIX 9 9 LEU A 112 ASN A 127 1 16 HELIX 10 10 THR A 131 LEU A 143 1 13 HELIX 11 11 GLN A 168 LEU A 174 1 7 HELIX 12 12 SER A 189 LYS A 205 1 17 HELIX 13 13 SER A 215 PHE A 220 5 6 HELIX 14 14 SER A 247 SER A 255 1 9 HELIX 15 15 LYS A 256 ILE A 258 5 3 HELIX 16 16 GLY B 10 GLU B 15 5 6 HELIX 17 17 ASP B 17 LEU B 21 5 5 HELIX 18 18 GLN B 32 GLU B 36 5 5 HELIX 19 19 ASN B 51 SER B 53 5 3 HELIX 20 20 LEU B 54 ASN B 68 1 15 HELIX 21 21 ASN B 88 THR B 94 1 7 HELIX 22 22 THR B 94 PHE B 99 1 6 HELIX 23 23 GLY B 105 LYS B 110 1 6 HELIX 24 24 LEU B 112 ASN B 127 1 16 HELIX 25 25 THR B 131 LEU B 143 1 13 HELIX 26 26 LYS B 190 LYS B 205 1 16 HELIX 27 27 SER B 215 PHE B 220 5 6 HELIX 28 28 SER B 247 SER B 255 1 9 SHEET 1 A 7 HIS A 103 LEU A 104 0 SHEET 2 A 7 GLU A 72 CYS A 78 1 N CYS A 78 O HIS A 103 SHEET 3 A 7 LYS A 44 TYR A 50 1 N VAL A 48 O MSE A 77 SHEET 4 A 7 ASP A 26 CYS A 30 1 N ARG A 29 O ALA A 47 SHEET 5 A 7 LYS A 3 ALA A 7 1 N ILE A 5 O PHE A 28 SHEET 6 A 7 GLU A 147 SER A 151 1 O TYR A 149 N VAL A 4 SHEET 7 A 7 LYS A 207 CYS A 210 1 O TYR A 209 N LEU A 150 SHEET 1 B 2 LYS A 38 TYR A 39 0 SHEET 2 B 2 GLN A 234 GLU A 235 -1 O GLN A 234 N TYR A 39 SHEET 1 C 7 HIS B 103 LEU B 104 0 SHEET 2 C 7 GLU B 72 CYS B 78 1 N CYS B 78 O HIS B 103 SHEET 3 C 7 LYS B 44 TYR B 50 1 N VAL B 48 O MSE B 77 SHEET 4 C 7 ASP B 26 CYS B 30 1 N ARG B 29 O PHE B 49 SHEET 5 C 7 LYS B 3 ALA B 7 1 N ILE B 5 O ASP B 26 SHEET 6 C 7 GLU B 147 SER B 151 1 O TYR B 149 N VAL B 4 SHEET 7 C 7 LYS B 207 CYS B 210 1 O TYR B 209 N LEU B 150 LINK C HIS A -1 N MSE A 1 1555 1555 1.33 LINK C MSE A 1 N LYS A 2 1555 1555 1.33 LINK C ILE A 76 N MSE A 77 1555 1555 1.33 LINK C MSE A 77 N CYS A 78 1555 1555 1.33 LINK C TYR A 135 N MSE A 136 1555 1555 1.33 LINK C MSE A 136 N CYS A 137 1555 1555 1.33 LINK C MSE B 1 N LYS B 2 1555 1555 1.33 LINK C ILE B 76 N MSE B 77 1555 1555 1.33 LINK C MSE B 77 N CYS B 78 1555 1555 1.33 LINK C TYR B 135 N MSE B 136 1555 1555 1.33 LINK C MSE B 136 N CYS B 137 1555 1555 1.33 SITE 1 AC1 12 GLY B 8 ASN B 9 GLY B 10 ASN B 31 SITE 2 AC1 12 GLN B 32 THR B 131 SER B 132 GLY B 133 SITE 3 AC1 12 ILE B 153 ASP B 154 PHE B 155 TYR B 156 SITE 1 AC2 17 GLY A 8 ASN A 9 GLY A 10 PRO A 11 SITE 2 AC2 17 ASN A 31 THR A 131 SER A 132 GLY A 133 SITE 3 AC2 17 GLY A 152 ILE A 153 ASP A 154 PHE A 155 SITE 4 AC2 17 TYR A 156 SER A 161 TYR A 162 HOH A2004 SITE 5 AC2 17 HOH A2022 CRYST1 115.434 115.434 41.059 90.00 90.00 90.00 P 4 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008663 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008663 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024355 0.00000